» Articles » PMID: 8341381

Compliance in Hemodialysis Patients: a Multivariate Regression Analysis

Overview
Journal Nephron
Publisher Karger
Specialty Nephrology
Date 1993 Jan 1
PMID 8341381
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Successful treatment of patients with end-stage renal failure requires, in addition to dialysis, strict control of dietary, fluid and medication intake. In the present study we measured, in 50 chronic hemodialysis patients, serum potassium (K), serum phosphate (PO4) and interdialytic weight gain as indices of diet, medication and fluid compliance, respectively. Dietary compliance did not correlate with fluid or medication compliance, whereas fluid intake and medication compliance were related (p = 0.01). Age, time on dialysis, place of birth and whether the patient came accompanied or not to the dialysis unit were the main variables affecting serum K levels. Sex, ethnic origin and education significantly affected serum PO4. Sex, place of birth, marital status, number of children and years of education affected fluid intake. The compliance of the hemodialysis patient with different aspects of his regimen is thus multifactorial. Attempts to improve compliance and thus reduce morbidity and mortality should be aimed at identifying the population with low compliance and exposing them to educational programs.

Citing Articles

Understanding the impact of haemodialysis on UK National Health Service patients' well-being: A qualitative investigation.

Jones D, Harvey K, Harris J, Butler L, Vaux E J Clin Nurs. 2017; 27(1-2):193-204.

PMID: 28498615 PMC: 6853155. DOI: 10.1111/jocn.13871.


Medication burden in CKD-5D: impact of dialysis modality and setting.

Parker K, Nikam M, Jayanti A, Mitra S Clin Kidney J. 2015; 7(6):557-61.

PMID: 25859372 PMC: 4389130. DOI: 10.1093/ckj/sfu091.


Serum phosphorus levels and pill burden are inversely associated with adherence in patients on hemodialysis.

Wang S, Alfieri T, Ramakrishnan K, Braunhofer P, Newsome B Nephrol Dial Transplant. 2013; 29(11):2092-9.

PMID: 24009281 PMC: 4209875. DOI: 10.1093/ndt/gft280.


Conversion to lanthanum carbonate monotherapy effectively controls serum phosphorus with a reduced tablet burden: a multicenter open-label study.

Vemuri N, Michelis M, Matalon A BMC Nephrol. 2011; 12:49.

PMID: 21962172 PMC: 3197476. DOI: 10.1186/1471-2369-12-49.


A systematic review of the prevalence and determinants of nonadherence to phosphate binding medication in patients with end-stage renal disease.

Karamanidou C, Clatworthy J, Weinman J, Horne R BMC Nephrol. 2008; 9:2.

PMID: 18237373 PMC: 2270809. DOI: 10.1186/1471-2369-9-2.